Harnessing the Immune System to Fight Disease: Getting it to Attack the Body’s Enemies, and not its Friends

February 18, 2021, 4:00 pm — 4:45 pm

Due to the COVID-19 outbreak, Precision Medicine Thursdays at Venture Café have moved to Zoom.

Join Zoom Meeting: Precision Medicine Thursday @ Venture Café – 2/18/2021

The Institute of Clinical and Translational Sciences (ICTS), in collaboration with Venture Café, is hosting Precision Medicine Series on the third Thursday of every month! This month at Precision Medicine Thursdays at Venture Café, join us to hear two researchers from the University of Missouri School of Medicine, Dr. Haval Shirwan and Dr. Esma Yolcu. Both are Professor of Molecular Microbiology and Immunology in the Department of Child Health.

This month at Precision Medicine Thursdays, University of MO-Columbia researchers Haval Shirwan and Esma Yolcu will present new therapeutics and technology to modify human immune response. Haval Shirwan will discuss development of a long-lasting biologic that encourages the immune system to prevent cancer in high-risk individuals by eliminating pre-cancer cells at inception. Esma Yolcu, in contrast, will discuss a technology designed to avoid a major limitation to bone marrow transplants, Graft-vs-Host Disease, where the immune system from the donor tissue attacks the recipient.

For more information, please contact Tricia Salyer, Precision Medicine Navigator at ICTS, at salyerp@wustl.edu.